Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Small Cap Fund median (37 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 20 Mar 2026 – 20 Aug 2026, limited by Abakkus Small Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Abakkus Small Cap Fund | Nifty Smallcap 250 |
|---|---|---|
| 20 Mar 2026 | ₹100.00 | ₹100.00 |
| 02 Apr 2026 | ₹100.06 | ₹99.54 |
| 15 Apr 2026 | ₹107.69 | ₹108.51 |
| 27 Apr 2026 | ₹110.97 | ₹112.99 |
| 10 May 2026 | ₹113.80 | ₹117.89 |
| 23 May 2026 | ₹110.90 | ₹113.41 |
| 05 Jun 2026 | ₹113.66 | ₹115.30 |
| 17 Jun 2026 | ₹118.03 | ₹118.28 |
| 30 Jun 2026 | ₹121.02 | ₹119.80 |
| 13 Jul 2026 | ₹123.86 | ₹122.85 |
| 26 Jul 2026 | ₹121.15 | ₹118.99 |
| 07 Aug 2026 | ₹126.05 | ₹124.10 |
| 20 Aug 2026 | ₹126.22 | ₹123.98 |
| Metric | Abakkus · Direct NAV ₹12.60 Very High risk Unrated | Category median Small Cap Fund · 37 funds |
|---|---|---|
| — | +12.86% | |
| — | +18.08% | |
| — | +18.44% | |
| — | +17.52% | |
| +26.22% | +19.96% | |
| +60.51% | — | |
| — | +21.45% | |
| — | +21.03% | |
| — | +19.53% | |
| Risk | ||
| 13.33% | 17.14% | |
| — | 0.69 | |
| — | 0.93 | |
| -4.28% | -32.37% | |
| Nifty Smallcap 250 | — | |
| — | +2.27% | |
| — | 0.86 | |
| — | 88.4% | |
| — | 77.8% | |
| 1.36% | 0.92% | |
| ₹964.59Cr | ₹4,512Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| — | 27% | |
| Sanjay Doshi · 0.5y | — | |
| 20 Mar 2026 | — | |
| 61 | — | |
| 17.6% | — | |
| 9.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.